Investigating the Adhesion of New Adhesive to the Skin
A Pilot Evaluation Exploring New Adhesive Materials and Their Ability to Handle Moisture From Abdominal and Peristomal Skin
1 other identifier
interventional
6
1 country
1
Brief Summary
The adhesion of the new adhesive strips is investigated on healthy volunteers
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2018
CompletedFirst Submitted
Initial submission to the registry
January 31, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2018
CompletedFirst Posted
Study publicly available on registry
February 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedJanuary 27, 2020
January 1, 2020
1 month
January 31, 2018
January 22, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Swelling of the adhesive
Swelling of adhesive strips measured by weight (difference between the weight of the strip before and after use)
24 hours
Study Arms (1)
Test of new adhesive strips
EXPERIMENTALThe subjects will test adhesives strips made of 4 different adhesives: Standard adhesive 1 Standard adhesive 2 PL4 PL16-L
Interventions
This strip contains a standard hydrocolloid adhesive found in ostomy devices
This strip contains a standard hydrocolloid adhesive found in ostomy devices
Eligibility Criteria
You may qualify if:
- Have given written informed consent
- Be at least 18 years of age and have full legal capacity
- Have intact skin on the area used in the investigation
You may not qualify if:
- Currently receiving or have within the past 2 months received radio- and/or chemotherapy
- Currently receiving or have within the past months received topical steroid treatment in the abdominal skin area or systemic steroid (tablet/injection) treatment.
- Are pregnant or breastfeeding
- Have dermatological problems in the abdominal area (assessed by investigator)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Coloplast A/Slead
Study Sites (1)
Coloplast A/S
Humlebæk, 3050, Denmark
Study Officials
- PRINCIPAL INVESTIGATOR
Lene F Nielsen
Head of the pre-clinical department
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2018
First Posted
February 20, 2018
Study Start
January 15, 2018
Primary Completion
February 15, 2018
Study Completion
June 30, 2020
Last Updated
January 27, 2020
Record last verified: 2020-01